Search Within

Karlo Perica

Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Hematology-Oncology Fellows (18)
  4. Center for Hematologic Malignancies (17)
  5. GSK Faculty (14)
  6. Hematologic Malignancies Research (14)

More Groups

People
  1. Michel Sadelain (12)
  2. Jae Park (5)
  3. Kevin Curran (5)
  4. Jessica Flynn (4)
  5. Sergio Giralt (4)
  6. Anton Dobrin (3)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Blood Advances (1)
  4. Cell Stem Cell (1)
  5. European Journal of Immunology (1)
  6. Human Gene Therapy (1)

More Publications

Publishers
  1. Nature Publishing Group (5)
  2. American Society of Hematology (4)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HIV immune evasin Nef enhances allogeneic CAR T cell potency
    Journal Article

    Perica, K.; Kotchetkov, I. S.; Mansilla-Soto, J.; Ehrich, F.; Herrera, K.; Shi, Y.; Dobrin, A.; Gönen, M.; Sadelain, M.
    Nature (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies
    Journal Article

    Hammer, Q.; Perica, K.; Mbofung, R. M.; van Ooijen, H.; Martin, K. E.; Momayyezi, P.; Varady, E.; Pan, Y.; Jelcic, M.; Groff, B.; more...
    Cell Stem Cell (2024)

    Fulltext@MSK | Save
  • Engineering immune-evasive allogeneic cellular immunotherapies
    Review

    Martin, K. E.; Hammer, Q.; Perica, K.; Sadelain, M.; Malmberg, K. J.
    Nature Reviews Immunology (2024)

    Fulltext@MSK | Save
  • Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
    Journal Article

    Dobrin, A.; Lindenbergh, P. L.; Shi, Y.; Perica, K.; Xie, H.; Jain, N.; Chow, A.; Wolchok, J. D.; Merghoub, T.; Sadelain, M.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Allogeneic CAR T cells with regulated NEF expression display immune evasion and optimized signaling
    Meeting Abstract

    Perica, K.; Mansilla-Soto, J.; Kotchetkov, I.; Sadelain, M.
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Combined genetic ablation of CD54 and CD58 in car engineered cytotoxic lymphocytes effectively averts allogeneic immune cell rejection
    Meeting Abstract

    Hammer, Q.; Perica, K.; Mbofung, R. M.; van Ooijen, H.; Varady, E.; Jelcic, M.; Pan, Y.; Momayyezi, P.; Groff, B.; Abujarour, R.; more...
    Blood (2022)

    Fulltext@MSK | Save